APLLTD₹760.10-2.71%
73/100
0100 · strongest
strong
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %APLLTD financial summary
For Mar 2026, Alembic Pharmaceuticals Ltd reported revenue of ₹6,651 crore, which grew 10.2% from the previous year. Net profit was ₹640 crore, which grew 27.2% year on year, on an operating margin of 16%. Earnings per share came in at ₹32.58. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹6,651 crore |
|---|---|
| Net profit | ₹640 crore |
| Operating margin | 16% |
| EPS | ₹32.58 |